LISTEN LIVE

ovarian cancer

Johnson & Johnson has been ordered to pay nearly $4.7 billion in damages to 22 women and their families who say asbestos found in the company's talcum powder contributed to their ovarian cancer.

The St. Louis Circuit Court jury awarded $4.14 billion in punitive damages and $550 million in compensatory damages to the plaintiffs, who said the company failed to warn about the cancer risks.

An experimental vaccine could be on the market for ovarian-cancer patients as soon as 2022, according to the Jacksonville-based company that makes it.

The River City’s Mayo Clinic is participating in the trials.

Moffitt Cancer Center

When the NCAA Women's Final Four comes to town, cancer researchers benefit. 

Since 2009, the Kay Yow Cancer Fund has awarded a women's cancer research grant to a research institution in the city hosting the NCAA Women's Final Four

Monday, Moffitt Cancer Center Professor of Oncology and Medicine Dr. Martine Extermann received the $250,000 grant.